Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

178,175 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Berzosertib Plus Topotecan vs Topotecan Alone in Patients With Relapsed Small Cell Lung Cancer: A Randomized Clinical Trial.
Takahashi N, Hao Z, Villaruz LC, Zhang J, Ruiz J, Petty WJ, Mamdani H, Riess JW, Nieva J, Pachecho JM, Fuld AD, Shum E, Chauhan A, Nichols S, Shimellis H, McGlone J, Sciuto L, Pinkiert D, Graham C, Shelat M, Kattappuram R, Abel M, Schroeder B, Upadhyay D, Krishnamurthy M, Sharma AK, Kumar R, Malin J, Schultz CW, Goyal S, Redon CE, Pommier Y, Aladjem MI, Gore SD, Steinberg SM, Vilimas R, Desai P, Thomas A. Takahashi N, et al. Among authors: zhang j. JAMA Oncol. 2023 Dec 1;9(12):1669-1677. doi: 10.1001/jamaoncol.2023.4025. JAMA Oncol. 2023. PMID: 37824137 Free PMC article. Clinical Trial.
Editorial: Prognostic factors in non-small cell lung cancer.
Rahouma M, Baudo M, Zhang J, Mutti L. Rahouma M, et al. Among authors: zhang j. Front Oncol. 2023 Mar 14;13:1174625. doi: 10.3389/fonc.2023.1174625. eCollection 2023. Front Oncol. 2023. PMID: 36998444 Free PMC article. No abstract available.
A Phase 2 Study of In Situ Oncolytic Virus Therapy and Stereotactic Body Radiation Therapy Followed by Pembrolizumab in Metastatic Non-Small Cell Lung Cancer.
Guan J, Sun K, Guerrero CA, Zheng J, Xu Y, Mathur S, Teh BS, Farach A, Zhang J, Butler E, Pan PY, Zsigmond E, Mei Z, Mejia J, Chen SH, Chang JC, Bernicker EH. Guan J, et al. Among authors: zhang j. Int J Radiat Oncol Biol Phys. 2024 Apr 1;118(5):1531-1540. doi: 10.1016/j.ijrobp.2023.08.044. Epub 2023 Aug 24. Int J Radiat Oncol Biol Phys. 2024. PMID: 37625523 Clinical Trial.
Impact of Infections in Patients Receiving Pembrolizumab-Based Therapies for Non-Small Cell Lung Cancer.
Burns EA, Gee K, Kieser RB, Xu J, Zhang Y, Crenshaw A, Muhsen IN, Mylavarapu C, Esmail A, Shah S, Umoru G, Sun K, Guerrero C, Gong Z, Heyne K, Singh M, Zhang J, Bernicker EH, Abdelrahim M. Burns EA, et al. Among authors: zhang j, zhang y. Cancers (Basel). 2022 Dec 23;15(1):81. doi: 10.3390/cancers15010081. Cancers (Basel). 2022. PMID: 36612078 Free PMC article.
Chemotherapy, immunotherapy, or combination first-line treatment for metastatic urothelial carcinoma of the bladder: A large real-world experience.
Ranganathan S, Riveros C, Xu J, Hu S, Geng M, Huang E, Melchiode Z, Zhang J, Efstathiou E, Chan KS, Wallis CJD, Sonpavde G, Satkunasivam R. Ranganathan S, et al. Among authors: zhang j. Urol Oncol. 2024 Sep;42(9):291.e13-291.e25. doi: 10.1016/j.urolonc.2024.04.006. Epub 2024 May 19. Urol Oncol. 2024. PMID: 38763801
Comparative real-world survival outcomes of metastatic papillary and clear cell renal cell carcinoma treated with immunotherapy, targeted therapy, and combination therapy.
Riveros C, Ranganathan S, Xu J, Chang C, Kaushik D, Morgan M, Miles BJ, Muhammad T, Anis M, Aghazadeh M, Zhang J, Efstathiou E, Klaassen Z, Brooks MA, Rini B, Wallis CJD, Satkunasivam R. Riveros C, et al. Among authors: zhang j. Urol Oncol. 2023 Mar;41(3):150.e1-150.e9. doi: 10.1016/j.urolonc.2022.11.022. Epub 2023 Jan 5. Urol Oncol. 2023. PMID: 36610815
178,175 results
You have reached the last available page of results. Please see the User Guide for more information.